Skip to content

Clinical trials

Myelodysplastic Syndromes trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: South Korea Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20082
20094
20104
20114
20125
20133
20144
20166
20172
20183
20193
20204
20213
20223
20231
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Unknown status9
Recruiting8
Active, not recruiting7
Terminated7
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center9
Novartis Pharmaceuticals9
Celgene4
Samsung Medical Center4
Bristol-Myers Squibb3
Cooperative Study Group A for Hematology3
GlaxoSmithKline3
Takeda3
Janssen Research & Development, LLC2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes63
Leukemia, Myeloid, Acute22
Leukemia, Myelomonocytic, Chronic13
Anemia7
Leukemia7
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Anemia, Refractory, with Excess of Blasts5
Leukemia, Myeloid, Accelerated Phase5
Leukemia, Myeloid, Chronic-Phase5
Multiple Myeloma5

Trials

Showing 76 to 63 of 63. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.